about
Melatonin prevents myeloperoxidase heme destruction and the generation of free iron mediated by self-generated hypochlorous acidPurification, characterization, and potential of saline waste water remediation of a polyextremophilic α-amylase from an obligate halophilic Aspergillus gracilisCyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trialBone morphogenetic proteins and their antagonists: current and emerging clinical uses.Development and validation of HPLC method for simultaneous estimation of piperine and guggulsterones in compound Unani formulation (tablets) and a nanoreservoir system.Estrogen-like effects of cadmium in vivo do not appear to be mediated via the classical estrogen receptor transcriptional pathwayCadmium-induced effects on cellular signaling pathways in the liver of transgenic estrogen reporter mice.Optimization strategies for HPLC enantioseparation of racemic drugs using polysaccharides and macrocyclic glycopeptide antibiotic chiral stationary phases.Analyses of anticancer drugs by capillary electrophoresis: a review.Chiral separation of beta-adrenergic blockers on CelluCoat column by HPLC.Separation of biological proteins by liquid chromatography.Short report: Limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia.Enantio-separation of drugs with multiple chiral centers by chromatography and capillary electrophoresis.The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cChiral xenobiotics bioaccumulations and environmental health prospectives.Development and validation of SPMMTE HPLC method for analysis of profens from human plasma.Enantiomeric resolution of multiple chiral centres racemates by capillary electrophoresis.Determination of chloramphenicol in biological matrices by solid-phase membrane micro-tip extraction and capillary electrophoresis.Impact of immobilized polysaccharide chiral stationary phases on enantiomeric separations.Role of racemization in optically active drugs development.Homochiral drug design and development by racemization.Supramolecular systems-based HPLC for chiral separation of beta-adrenergics and beta-adrenolytics in drug discovery schemes.Tracing contacts of TB patients in Malaysia: costs and practicality.Hyphenation in sample preparation: advancement from the micro to the nano world.Supramolecular chiro-biomedical assays and enantioselective HPLC analyses for evaluation of profens as non-steroidal anti-inflammatory drugs, potential anticancer agents and common xenobiotics.Advances in nano drugs for cancer chemotherapy.The dosimetric impact of daily setup error on target volumes and surrounding normal tissue in the treatment of prostate cancer with intensity-modulated radiation therapy.New generation adsorbents for water treatment.Recent trends in ultra-fast HPLC: new generation superficially porous silica columns.Recent advances in SPE-chiral-HPLC methods for enantiomeric separation of chiral drugs in biological samples.Advances in chiral separations by nonaqueous capillary electrophoresis in pharmaceutical and biomedical analysis.The genus Pluchea: phytochemistry, traditional uses, and biological activities.Advances in chiral separations of small peptides by capillary electrophoresis and chromatography.Automatic semantic classification of scientific literature according to the hallmarks of cancerIonic Liquids in HPLC and CE: A Hope for Future.Agarose- and alginate-based biopolymers for sample preparation: Excellent green extraction tools for this century.Advances in Nanocarriers for Anticancer Drugs Delivery.Variation of volatiles in Tunisian populations of Thymbra capitata (L.) Cav. (Lamiaceae).A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma.Cadmium at nanomolar concentrations activates Raf-MEK-ERK1/2 MAPKs signaling via EGFR in human cancer cell lines.
P50
Q28545738-593B3F3E-B961-403F-B938-E02CF66D3349Q28658452-E53742F7-6982-4C6B-87DA-AA13F34A6121Q33503521-296E10B6-A077-425F-BA2B-BDB77792D87CQ34025148-3676918F-5427-4EFB-A36A-7CD20B7AC740Q34116022-6CC350CE-B1F0-4945-B595-27A66AB0ED0BQ34119145-E85888E8-CA47-4601-ADA0-1DD6978B0B78Q34252800-9B562A2C-CAC7-42BF-AE72-243CDD006DA3Q34774862-C61DA9B0-036B-4AA1-8C7F-4CAB1E2F5BA4Q34811445-21FD9C7A-4B5E-4533-BE5D-9D3CB8E19415Q34940517-445E9C7C-4615-4202-AB25-51140A94D8F6Q34957698-F326CDF1-664F-47D5-9F19-4742223D0B0AQ34987689-1DCCEF10-FCAB-4110-A83A-71EC17B1962FQ35213968-482915D1-A403-4298-A17E-26B82E1DC1BBQ35569473-B0CE36E5-4706-4A40-928F-6F17A5DEE0D9Q35684458-9777F86E-AD7B-47AD-A22E-3A5D671E4AE1Q35873553-11DEA11C-0734-420D-89B2-1734B7DF5657Q35912976-9D0A470B-6F1B-4F05-9B9D-2F0CF7F62D47Q36030714-70287DD4-F8E5-4558-B96C-DC1531721B89Q36531843-E27AFBD4-1F60-4B29-AAE5-5F3FB884EFC0Q36773723-FBC4DFAD-2F28-4F63-8AED-9CCC67DB1B60Q36952083-3378BC54-2EF7-4B00-A6BC-C3F8B9BAAEC3Q37017722-3936C814-FB50-4408-A601-F2885A52EDEAQ37052181-741733FE-4EFF-405A-B4A4-316B2E11089CQ37211997-5E156A6D-0025-4D20-BAEC-338642D5E2A3Q37233021-49AAC7CD-7F2B-41C4-A40F-3FC7E766253DQ37821030-9A9D103A-A18B-492F-9EA9-F61AAFEDA664Q38005509-2E1551A2-825C-4D28-90BA-35ABCDB5CC3AQ38021484-57BE4FFA-D46B-4282-BB8E-9BE2D845882BQ38062866-4BC0F4E5-27E8-4CFE-B206-399721D4EBF4Q38078807-4D14B52D-567A-4673-A637-50223FDC9CF1Q38126456-90224CFE-B11E-487A-A266-E3A30CABFE7DQ38163495-D4501F1F-4B02-4350-A33E-4E8916512C02Q38232005-FEC8EFA5-32E1-4EA2-9145-30EAB7FD3219Q38402184-9A04C325-B741-45BA-A662-0562A075E081Q38749720-EFB24044-7FC9-4832-B422-22CDB98551C6Q38793405-72D8390B-2E3D-4180-9B85-291BF27B3FC8Q38799003-40FB3DA1-C40C-4165-8397-470B314B8782Q38868868-EE7B328D-4F08-4703-BB25-C2DB3E935068Q38883245-257393A2-C444-47A7-ACB8-6D2D2071E5A5Q38903134-D266F1FB-2780-47E2-9119-E3422E683A32
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Imran Ali
@ast
Imran Ali
@en
Imran Ali
@es
Imran Ali
@nl
Imran Ali
@sl
type
label
Imran Ali
@ast
Imran Ali
@en
Imran Ali
@es
Imran Ali
@nl
Imran Ali
@sl
prefLabel
Imran Ali
@ast
Imran Ali
@en
Imran Ali
@es
Imran Ali
@nl
Imran Ali
@sl
P1006
P214
P244
P1006
P1053
F-7710-2010
P106
P21
P213
0000 0001 1616 3419
P214
P244
nb2003094944
P31
P3829
P496
0000-0001-6511-8374
P569
1943-01-01T00:00:00Z
P7859
lccn-nb2003094944